290 related articles for article (PubMed ID: 20071745)
1. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing.
Goers ES; Purcell J; Voelker RB; Gates DP; Berglund JA
Nucleic Acids Res; 2010 Apr; 38(7):2467-84. PubMed ID: 20071745
[TBL] [Abstract][Full Text] [Related]
2. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.
Yuan Y; Compton SA; Sobczak K; Stenberg MG; Thornton CA; Griffith JD; Swanson MS
Nucleic Acids Res; 2007; 35(16):5474-86. PubMed ID: 17702765
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
4. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
[TBL] [Abstract][Full Text] [Related]
5. Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility.
deLorimier E; Hinman MN; Copperman J; Datta K; Guenza M; Berglund JA
J Biol Chem; 2017 Mar; 292(10):4350-4357. PubMed ID: 28130447
[TBL] [Abstract][Full Text] [Related]
6. An engineered RNA binding protein with improved splicing regulation.
Hale MA; Richardson JI; Day RC; McConnell OL; Arboleda J; Wang ET; Berglund JA
Nucleic Acids Res; 2018 Apr; 46(6):3152-3168. PubMed ID: 29309648
[TBL] [Abstract][Full Text] [Related]
7. Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron.
Echeverria GV; Cooper TA
Nucleic Acids Res; 2014 Feb; 42(3):1893-903. PubMed ID: 24185704
[TBL] [Abstract][Full Text] [Related]
8. The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing.
Warf MB; Diegel JV; von Hippel PH; Berglund JA
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9203-8. PubMed ID: 19470458
[TBL] [Abstract][Full Text] [Related]
9. Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.
Tran H; Gourrier N; Lemercier-Neuillet C; Dhaenens CM; Vautrin A; Fernandez-Gomez FJ; Arandel L; Carpentier C; Obriot H; Eddarkaoui S; Delattre L; Van Brussels E; Holt I; Morris GE; Sablonnière B; Buée L; Charlet-Berguerand N; Schraen-Maschke S; Furling D; Behm-Ansmant I; Branlant C; Caillet-Boudin ML; Sergeant N
J Biol Chem; 2011 May; 286(18):16435-46. PubMed ID: 21454535
[TBL] [Abstract][Full Text] [Related]
10. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
[TBL] [Abstract][Full Text] [Related]
11. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
[TBL] [Abstract][Full Text] [Related]
12. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
Dansithong W; Paul S; Comai L; Reddy S
J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
[TBL] [Abstract][Full Text] [Related]
13. Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.
Gates DP; Coonrod LA; Berglund JA
J Biol Chem; 2011 Sep; 286(39):34224-33. PubMed ID: 21832083
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
Dhaenens CM; Schraen-Maschke S; Tran H; Vingtdeux V; Ghanem D; Leroy O; Delplanque J; Vanbrussel E; Delacourte A; Vermersch P; Maurage CA; Gruffat H; Sergeant A; Mahadevan MS; Ishiura S; Buée L; Cooper TA; Caillet-Boudin ML; Charlet-Berguerand N; Sablonnière B; Sergeant N
Exp Neurol; 2008 Apr; 210(2):467-78. PubMed ID: 18177861
[TBL] [Abstract][Full Text] [Related]
15. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
[TBL] [Abstract][Full Text] [Related]
16. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
Terenzi F; Ladd AN
RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
[TBL] [Abstract][Full Text] [Related]
17. The Dimeric Form of 1,3-Diaminoisoquinoline Derivative Rescued the Mis-splicing of Atp2a1 and Clcn1 Genes in Myotonic Dystrophy Type 1 Mouse Model.
Matsumoto J; Nakamori M; Okamoto T; Murata A; Dohno C; Nakatani K
Chemistry; 2020 Nov; 26(63):14305-14309. PubMed ID: 32449537
[TBL] [Abstract][Full Text] [Related]
18. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
[TBL] [Abstract][Full Text] [Related]
19. Autoregulation of MBNL1 function by exon 1 exclusion from MBNL1 transcript.
Konieczny P; Stepniak-Konieczna E; Taylor K; Sznajder LJ; Sobczak K
Nucleic Acids Res; 2017 Feb; 45(4):1760-1775. PubMed ID: 27903900
[TBL] [Abstract][Full Text] [Related]
20. A systematic analysis of intronic sequences downstream of 5' splice sites reveals a widespread role for U-rich motifs and TIA1/TIAL1 proteins in alternative splicing regulation.
Aznarez I; Barash Y; Shai O; He D; Zielenski J; Tsui LC; Parkinson J; Frey BJ; Rommens JM; Blencowe BJ
Genome Res; 2008 Aug; 18(8):1247-58. PubMed ID: 18456862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
